Cefoperazone PCD Pharma Franchise Company

Cafoli Lifecare offers a Cefoperazone range of 11 injectable formulations, manufactured in WHO-GMP certified facilities. Distributors supplying hospitals and critical-care units can secure district-wise monopoly franchise rights for this third-generation cephalosporin, including its widely used sulbactam combination, with full promotional support.

What is Cefoperazone?

Cefoperazone is a third-generation cephalosporin antibiotic given by injection. It inhibits bacterial cell-wall synthesis and covers a broad range of Gram-negative and Gram-positive organisms; combined with the beta-lactamase inhibitor sulbactam, its spectrum extends to many resistant hospital pathogens. Reference: PubChem - Cefoperazone.

Available Forms

The Cafoli Cefoperazone portfolio is offered as Injection (dry powder vials), predominantly as cefoperazone-sulbactam combinations in various ratios for hospital use. Contact us for current pack presentations and combinations.

Therapeutic Applications

Cefoperazone (with sulbactam) is used for serious respiratory, urinary, intra-abdominal, biliary, skin and soft-tissue infections and septicaemia, particularly hospital-acquired and resistant infections. Prescribers include intensivists, surgeons, physicians and pulmonologists.

Why Cefoperazone is a High-Potential Molecule for Distributors

Cefoperazone-sulbactam is one of the most prescribed injectable antibiotics in Indian hospitals, valued for its coverage of resistant Gram-negative infections. As a high-value, high-turnover institutional product with steady ICU and surgical demand, it is a cornerstone line for any distributor supplying nursing homes and hospitals.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Cefoperazone
2. PubMed: cefoperazone-sulbactam
3. StatPearls / NCBI Bookshelf: Cephalosporins